Found: 23
Select item for more details and to access through your institution.
Pharmacogenomic Applications in Oncology.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
The pharmacist's responsibility to ensure appropriate use of direct‐to‐consumer genetic testing.
- Published in:
- JACCP: Journal of the American College of Clinical Pharmacy, 2021, v. 4, n. 5, p. 652, doi. 10.1002/jac5.1437
- By:
- Publication type:
- Article
Precision medicine approaches for the management of Ewing sarcoma: current perspectives.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2019, v. 12, p. 9, doi. 10.2147/PGPM.S170612
- By:
- Publication type:
- Article
Integration of a clinical pharmacist into the hematology--oncology clinics at an academic medical center.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 7, p. 613, doi. 10.2146/ajhp100414
- By:
- Publication type:
- Article
Novel and Expanded Oncology Drug Approvals of 2016: PART 2: New Options in the Management of Hematologic Malignancies.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 2, p. 138
- By:
- Publication type:
- Article
Novel and Expanded Oncology Drug Approvals of 2016: PART 1: New Options in Solid Tumor Management.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 2, p. 110
- By:
- Publication type:
- Article
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 5, p. 1122, doi. 10.1111/bcp.12665
- By:
- Publication type:
- Article
Pilot study of rosiglitazone as an in vivo probe of paclitaxel exposure.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 74, n. 1, p. 197, doi. 10.1111/j.1365-2125.2012.04165.x
- By:
- Publication type:
- Article
Developing Drugs for Tissue‐Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 334, doi. 10.1002/cpt.1946
- By:
- Publication type:
- Article
Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 3, p. 783, doi. 10.1007/s00415-019-09575-8
- By:
- Publication type:
- Article
The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumors.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Quantitation of Targetable Somatic Mutations Among Patients Evaluated by a Personalized Medicine Clinical Service: Considerations for Off-Label Drug Use.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 9, p. 1043, doi. 10.1002/phar.1917
- By:
- Publication type:
- Article
Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status.
- Published in:
- Oncologist, 2022, v. 27, n. 4, p. 307, doi. 10.1093/oncolo/oyac018
- By:
- Publication type:
- Article
Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
- Published in:
- Oncologist, 2017, v. 22, n. 2, p. 144, doi. 10.1634/theoncologist.2016-0195
- By:
- Publication type:
- Article
Pharmacoepidemiology of Clinically Relevant Hypothyroidism and Hypertension from Sunitinib and Sorafenib.
- Published in:
- Oncologist, 2017, v. 22, n. 2, p. 208, doi. 10.1634/theoncologist.2016-0233
- By:
- Publication type:
- Article
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 795, doi. 10.1634/theoncologist.2015-0480
- By:
- Publication type:
- Article
A Community-Based Multicenter Trial of Pharmacokinetically Guided 5-Fluorouracil Dosing for Personalized Colorectal Cancer Therapy.
- Published in:
- Oncologist, 2014, v. 19, n. 9, p. 959, doi. 10.1634/theoncologist.2014-0132
- By:
- Publication type:
- Article
Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Regorafenib: A Novel Multitargeted Tyrosine Kinase Inhibitor for Colorectal Cancer and Gastrointestinal Stromal Tumors.
- Published in:
- Annals of Pharmacotherapy, 2013, v. 47, n. 12, p. 1685, doi. 10.1177/1060028013509792
- By:
- Publication type:
- Article
Sylatron: A Pegylated Interferon for Use in Melanoma.
- Published in:
- Annals of Pharmacotherapy, 2012, v. 46, n. 6, p. 830, doi. 10.1345/aph.1Q791
- By:
- Publication type:
- Article
Validation of Doripenem Dosing in Patients with End-Stage Renal Disease Receiving Hemodialysis.
- Published in:
- Annals of Pharmacotherapy, 2011, v. 45, n. 11, p. 1455, doi. 10.1345/aph.1Q395
- By:
- Publication type:
- Article
Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With V600E-Mutated Gliomas.
- Published in:
- 2021
- By:
- Publication type:
- journal article